Hims & Hers Labs
Rating applies to: Broad multi-biomarker panels in people without symptoms. It is not a rating or endorsement of Hims & Hers Labs as a company or of its quality, safety or results.
According to the company, a plan of two Quest blood draws a year (75+ then 55+ biomarkers) with an action plan and provider messaging. The company also offers other services not covered here, including prescribing.
Descriptions are based on publicly available information and are not independently verified. Features, pricing and availability change; confirm with the provider.
Company-reported details
Hims & Hers also offers other services that are not covered or evaluated here, including telehealth care and prescription treatment. The company says its Labs action plan can include access to personalized treatment plans if a provider deems them appropriate. Only the testing is described here.
According to the company's own pages, checked October 16, 2026. Not independently verified; confirm on the company's site. Rules for consumer-ordered tests vary by state.
- Biomarkers / tests
- Up to 130+ biomarkers per year: first panel 75+, six-month follow-up 55+
- Care-team access
- A licensed provider reviews the request, results go to you and a provider, a provider reaches out about critical results, and 24/7 provider messaging is included; the company says a video visit is not required
- Reports and tracking
- Doctor-developed Action Plan, Biological Age estimate, retest at six months
- Price model
- Annual plan with two blood draws
- Price (as listed)
- $349 per year (listed at $499 before a discount)
- Physician order
- Company states "Eligibility and provider order required"; a licensed provider determines whether testing is appropriate
- State availability
- Company says available in 49 states and DC, not yet Hawaii; HSA/FSA not accepted for Labs per its FAQ
- Company pages
- Labs biomarkersLabs FAQ
See the lab testing comparison. Not medical advice.
About this evidence rating
A Cochrane review of general health checks concluded they are unlikely to be beneficial for reducing illness or death. Specific panels have not, to our knowledge, been shown in trials to improve outcomes. Individual tests within a panel may still be clinically useful.
This is an editorial opinion based on publicly available research, not medical advice or a regulatory determination. How ratings work. Last reviewed October 16, 2026.
Things to consider
- Broad panels can return incidental or borderline results that lead to follow-up testing; discuss with a clinician.
- Panel contents, pricing and clinician involvement differ by provider and change over time; check each provider's current terms.
- Discuss results and any next steps with a licensed clinician.
- Pricing
- Pricing varies; check the provider's site
- Regions (as reported; verify)
- US
Sources
Links are provided for reference. Citing a study does not imply its authors endorse this site or any product.
Some links on this site may be affiliate links; we may earn a commission if you buy through them, at no extra cost to you. Affiliate relationships and paid placements never change evidence ratings.
Longevity Ledger provides general information, not medical advice. Ratings are editorial opinions based on publicly available information. Consult a licensed clinician before changing medication, hormones, supplements, testing or training. Some links are affiliate or sponsored links; see our affiliate disclosure.